Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In patients who receive an organ transplant, their body considers this organ as foreign and
attempts to destroy it. This is called rejection. All patients who receive an organ
transplant, will take a combination of anti-rejection medications. These medications prevent
the new organ from being rejected from the body. FTY720 is a new compound that helps prevent
organ rejection.